Clinical Trials Arena November 14, 2025
While digital twins have progressed, there are still a range of ethical, regulatory and data-driven hurdles that must be overcome, notes Roche’s Dimitris Christopoulous.
In recent years, automation and artificial intelligence (AI) have been huge trends within the clinical trials landscape, as companies look to incorporate such technologies to optimise their operational efficiency.
Alongside the burgeoning growth of AI in the sector, digital twin technology is emerging as a powerful tool – one that could help shape the future of clinical trials.
This technology, which has its roots in the factory setting, could one day allow clinical trial operators to create a dynamic, virtual replica of a patient’s physiology. In theory, this could allow operators to predict how a patient...







